Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


We outline and evaluate competing explanations of three relationships that have consistently been found between cannabis use and the use of other illicit drugs, namely, (1) that cannabis use typically precedes the use of other illicit drugs; and that (2) the earlier cannabis is used, and (3) the more regularly it is used, the more likely a young person is to use other illicit drugs. We consider three major competing explanations of these patterns: (1) that the relationship is due to the fact that there is a shared illicit market for cannabis and other drugs which makes it more likely that other illicit drugs will be used if cannabis is used; (2) that they are explained by the characteristics of those who use cannabis; and (3) that they reflect a causal relationship in which the pharmacological effects of cannabis on brain function increase the likelihood of using other illicit drugs. These explanations are evaluated in the light of evidence from longitudinal epidemiological studies, simulation studies, discordant twin studies and animal studies. The available evidence indicates that the association reflects in part but is not wholly explained by: (1) the selective recruitment to heavy cannabis use of persons with pre-existing traits (that may be in part genetic) that predispose to the use of a variety of different drugs; (2) the affiliation of cannabis users with drug using peers in settings that provide more opportunities to use other illicit drugs at an earlier age; (3) supported by socialisation into an illicit drug subculture with favourable attitudes towards the use of other illicit drugs. Animal studies have raised the possibility that regular cannabis use may have pharmacological effects on brain function that increase the likelihood of using other drugs. We conclude with suggestions for the type of research studies that will enable a decision to be made about the relative contributions that social context, individual characteristics, and drug effects make to the relationship between cannabis use and the use of other drugs.

References 


Articles referenced by this article (66)

  • Kandel, DB. Stages and pathways of drug involvement: examining the gateway hypothesis 2002; edNew York: Cambridge University Press

  • DuPont, RL. Getting tough on gateway drugs: a guide for the family 1984; Washington, DC: American Psychiatric Press

  • Polich, JM, Ellickson, PL, Reuter, P, Kahan, JP. Strategies for controlling adolescent drug use 1984; Santa Monica, CA: Rand Corporation

  • de Kort, M, Cramer, T. Pragmatism versus ideology: Dutch drug policy continued J Drug Issues, 1999; 29(3): 473 – 492

  • Morral, AR, McCaffrey, DF, Paddock, SM. Reassessing the marijuana gateway effect Addiction, 2002; 97(12): 1493 – 504

  • Kandel, D. Stages in adolescent involvement in drug use Science, 1975; 190: 912 – 914

  • Golub, A, Johnson, BD. Substance use progression and hard drug use in inner-city New York 2002; p. 90 – 112 In: Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesisCambridge, UK: Cambridge University Press

  • Kandel, DB. Marijuana users in young adulthood Arch Gen Psychiatry, 1984; 41(2): 200 – 9

  • Donnelly, N, Hall, WD. Patterns of cannabis use in Australia 1994; Canberra: Australian Government Publishing Service

  • Donovan, JE, Jessor, R. Problem drinking and the dimension of involvement with drugs: a Guttman scalogram analysis of adolescent drug use Am J Public Health, 1983; 73(5): 543 – 52

Show 10 more references (10 of 66)

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/1674921
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/1674921

Article citations


Go to all (119) article citations